FEBRUARY 2020

ActivePharmaceutical

IngredientsCatalog

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

Canagli�ozin*

Dapagli�ozin*

Empagli�ozin*

Glimepiride

Linagliptin

PioglitazoneHydrochloride

SitagliptinHydrochloride

SitagliptinPhosphate

Abacavir Base

Gati�oxacin

Levo�oxacinHemihydrateMoxi�oxacin

Hydrochloride

Posaconazole

Terbina�neHydrochloride

Voriconazole

AmlodipineBesylate

Apixaban

AtorvastatinCalcium*

ClopidogrelBisulfate*

DabigatranEtexilate Mesylate

DoxazosinMesylate

EnalaprilMaleate

FondaparinuxSodium

Irbesartan

ANTI

-DIA

BETI

CCA

RDIO

VASC

ULAR

ANTI

-INF

ECTI

VE

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Nateglinide Available

Liraglutide UD

Semaglutide UD

LosartanPotassium Available

Iron Sucrose(Available for selected markets)

Lacidipine

Available

Available

MetoprololSuccinate Available

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

PrasugrelHydrochloride

Ramipril

Ranolazine

Rivaroxaban

Sacubitril /Valsartan

Telmisartan

Ticagrelor

Treprostinil

Valsartan

AsenapineMaleate

AtomoxetineHydrochloride

BenztropineMesylate

Dimethyl Fumarate

Divalproex Sodium

Donepezil HCl

EscitalopramOxalate

EslicarbazepineAcetate

Eszopiclone

FingolimodHydrochloride

Glatiramer Acetate

Levetiracetam

LurasidoneHydrochloride

MemantineHydrochloride

Olanzapine

CNS

CARD

IOVA

SCUL

AR

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Roxadustat UD

UD

Clopidogrel Form 2 UD

Ferric Carboxymaltose (Available for selected markets)

Ferumoxytol(Available for selected markets)

UD

UD

Pregabalin Available

Bempedoic Acid

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

QuetiapineFumarate

Risperidone

RivastigmineHydrogen Tartrat

TizanidineHydrochloride

VilazodoneHydrochloride

ZiprasidoneHydrochloride

EsomeprazoleMagnesium*

Famotidine

Lubiprostone

Nizatidine

Obeticholic Acid

Omeprazole

OmeprazoleMagnesium

PantoprazoleSodium

RabeprazoleSodium

Apremilast*

Estradiol

RaloxifeneHydrochloride

AbirateroneAcetate

Azacitidine

BendamustineHydrochloride

Bortezomib

Cabazitaxel

Capecitabine

Car�lzomib

ONCO

LOGY

GAST

RO-I

NTES

TINA

LCN

SM

USCU

LO-

SKEL

ETAL

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Siponimod UD

Edaravone UD

Linaclotide UD

Abaloparatide UD

Dasatinib(Available for selected markets) Available

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

Decitabine

Docetaxel

Enzalutamide

GemcitabineHydrochloride

Granisteron

IbandronateSodium

Ibrutinib*

Lenalidomide

Lenvatinib

Letrozole

Lomustine(Available for selected markets)

NilotinibHydrochloride

OndansetronHydrochloride

Palbociclib

PalonosetronHydrochloride

PemetrexedDisodium*

PemetrexedDitromethamine

Plerixafor

Pomalidomide

Venetoclax

Zoledronic Acid

Eribulin(Available for selected markets)

Fosaprepitant

Midostaurin

ONCO

LOGY

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

UD

UD

UD

UD

UD

UD

Apalutamide UD

Olaparib

Pazopanib

RuxolitinibPhosphate

T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZILT H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL

CetirizineDihydrochloride

Desloratadine

FexofenadineHydrochlorideLevocetirizine

Dihydrochloride

MontelukastSodium

Za�rlukast

Dutasteride

EliglustatHemitartrate*

Febuxostat

Finasteride

Mirabegron*

Testosterone

Icatibant Acetate

Li�tegrast

LorcaserinHydrochloride

Permethrin

SugammadexSodium

Pidotimod

CinacalcetHydrochloride

Elagolix Sodium

UROL

OGY

RESP

IRAT

ORY

OTHE

RS

KetorolacTromethamine

Naproxen

NaproxenSodium

NaratriptanHydrochloride

SumatriptanSuccinatePA

IN M

ANAG

EMEN

T

Available

Available

Available

Available

Available

UD

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

Available

UD

UD

UD

UD

UD

Diroximel Fumarate

Lasmiditan

Tofacitinib

Varenicline Tartrate

February 2020

Disclaimer: No information in this catalog - including any reference to any product or service - constitutes an o�er for sale, or be construed as representing an o�er for sale. Products protected under valid patents are not o�ered or supplied for commercial use. However, the research quantities of such products may be o�ered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.

OTHER PIPELINE PRODUCTS

Development timeline to be checked with the Sales Manager

PRODUCT NAMETHERAPY AREA DR. REDDY’S IP ORAL INJ

Dacomitinib

Erda�tinib

Encequidar Mesylate

Larotrectinib sulfate

Selinexor

ONCOLOGY

ONCOLOGY & OBSTETRICS/ GYNECOLOGY Relugolix

NASH

Filgotinib

Ela�branor

LumateperonePSYCHIATRY

AUTOIMMUNE/ IMMUNOLOGY